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Abstract
Objective To evaluate the most common bacterial pathogens associated with septic
keratitis in veterinary patients from Switzerland. The second objective was to analyze
antibiotic susceptibility test results of the identified bacterial pathogens. The third
objective was to evaluate potential breed predispositions to septic keratitis.
Procedures Two hundred and fifty-five cultures and antibiotic susceptibility reports
from dogs, cats, and horses with septic keratitis that were presented to the University
of Zurich Veterinary Medical Teaching Hospital between 2009 and 2013 were
reviewed. Odds ratios for the risk of having a septic keratitis were estimated for all
dog and cat breeds compared to the general nonbrachycephalic hospital population.
Results Ninety-six, 29, and 31 positive cultures were obtained from 89 canine, 28
feline, and 29 equine eyes, respectively. Repeat sampling accounted for the differences
in numbers. Negative culture results were obtained in 50, 31, and 18 cases.
Staphylococci and streptococci accounted for 66% of the isolates in dogs and 80% of
the isolates in cats and horses. Staphylococcus spp. had a higher percentage of fluoro-
quinolone-resistant isolates compared to previous reports. Brachycephalic breeds had
elevated odds ratios for the presence of septic keratitis.
Conclusion Identified bacterial pathogens and their prevalence as well as the elevated
odds ratios for septic keratitis in brachycephalics are roughly consistent with previous
studies. Based on systemic breakpoint data, resistance to commonly used topical
antibiotics, including the second-generation fluoroquinolones, was found.
Key Words: bacterial resistance, cat, dog, horse, susceptibility test, ulcerative keratitis
INTRODUCTION
Corneal infections in the form of malacic ulcers are com-
mon and potentially devastating diseases treated by veteri-
nary- and human ophthalmologists alike.1–3 Many
literature references support this statement, but precise
prevalence numbers have not been published in the veteri-
nary literature.4–8 Almost 20% (2194/12085) of all oph-
thalmic small animal patients and 30% (548/1858) of all
ophthalmic equine patients seen in our clinic during the
last 20 years presented with a corneal defect. (Patient
database 1995–2014, Section of Veterinary Ophthalmol-
ogy, Vetsuisse Faculty, University of Zurich).
Bacterial infection and the subsequent inflammation of
the cornea can cause keratomalacia/corneal melting, a
result of activated enzymes such as collagenases, elastases,
matrix metalloproteinases (MMPs), and cathepsins and an
imbalance between these proteolytic enzymes and the pro-
teinase inhibitors present in the cornea and precorneal
tear film.9,10 The malacic process can lead to corneal ulcer
deepening, descemetocele formation, and corneal perfora-
tion.4,11
Previous studies demonstrated that the most frequently
isolated species of bacteria causing corneal infections are
Staphylococcus spp., Streptococcus spp., and Pseudomonas spp. in
dogs;8,12–14 and Pseudomonas spp., Streptococcus spp., and Sta-
phylococcus spp. in horses.15–17 The most frequently isolated
species of bacteria from the ocular surface of healthy cats
were Staphylococcus spp., Pseudomonas spp., Pasteurella spp.,
and beta-hemolytic Streptococcus spp.18
A first-choice antibiotic for treatment of ocular surface
infections in our clinic is a triple-antibiotic formulation
containing neomycin, polymyxin B, and bacitracin or
gramicidin. Other topically applied antibiotics used for
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corneal diseases in veterinary ophthalmology include
tobramycin, gentamicin, ciprofloxacin, ofloxacin, moxi-
floxacin, chloramphenicol, oxytetracycline, and ery-
thromycin.19
In a 2006 study of 97 dogs with bacterial keratitis,
Tolar et al.8 observed no significant changes in the resis-
tance patterns to selected antibiotics over an 11-year per-
iod from 1993 to 2003. Nonetheless, a number of studies
of bacterial keratitis report antibacterial resistance devel-
opment in veterinary medicine,15,17 and in human
medicine.20–23
The primary objective of this study was to evaluate the
most common bacterial pathogens associated with septic
keratitis in veterinary patients from Switzerland. The sec-
ond objective was to analyze the susceptibility of the iden-
tified bacterial pathogens to antibiotics, including a
potential shift in prevalence and antibiotic resistance over
time. The third objective was to evaluate potential breed
predispositions to septic keratitis within the hospital popu-
lation. Patients originated from all sections of the country
and from neighboring countries, offering a good regional
overview.
MATERIALS AND METHODS
Case selection: inclusion and exclusion criteria
The reports of 425 samples obtained from dogs, cats, and
horses submitted for bacteriologic culture and antibiotic
susceptibility testing by the ophthalmology section at the
Vetsuisse Faculty, University of Zurich, between January
2009 and December 2013 were collected. Reports were
included if the case history (OblonData Praxissoftware)
identified a corneal defect including keratitis, erosion, sim-
ple-, complicated- or malacic ulcer, descemetocele, corneal
laceration or perforation, corneal abscess, or corneal for-
eign body; and the case history also suggested a clinical
suspicion for a septic process. Reports were excluded if a
case history was not available or yielded inadequate infor-
mation or if an antibiotic susceptibility test was not avail-
able (22 reports), if the patient was not diagnosed with a
keratopathy (138 reports), or in cases that were culture
positive for Mycoplasma spp., Chlamydophila spp., or Lep-
tospira spp. (10 reports).
Sampling and sample processing
Samples were collected from corneas with sterile swabs,
after administration of one drop of topical anesthetic.
Oxybuprocaine (Novesin 0.4%, OmniVision) was used in
dogs and cats, and proxymetacaine (Alcaine, Alcon) was
used in horses. Swabs were kept in Amies Medium after
sample collection until further analysis. Most samples were
processed by IDEXX Diavet AG (B€ach, Switzerland). In
some cases, samples were processed by the Institute of
Veterinary Bacteriology (IVB), University of Zurich, and
one case was analyzed by the Institute of Veterinary Bac-
teriology (ZOBA), University of Berne. Samples were
inoculated on- and into various culture media: Columbia
Agar with 5% sheep blood, MacConkey Agar, Columbia
CNA agar with 5% sheep blood, Schaedler Agar with 5%
sheep blood, Schaedler Bouillon for enrichment/accumula-
tion (culture media by BD: Becton Dickinson and Com-
pany 3). After a 24- to 72-h incubation period, individual
colonies were further analyzed using standard bacteriolog-
ical procedures (gram stain, catalase test, oxidase test,
PYR test, oxidation–fermentation test, agglutination test
for coagulase activity, agglutination test for the classifica-
tion of Streptococcus spp. Lancefield groups and growth per-
formance on various agars). Additionally, colonies were
identified using the Vitek (Biomerieux, Marcy l‘Etoile,
France) automated microbial identification system.
Antibiotic susceptibility testing was performed using the
agar disk diffusion test (Mueller Hinton Agar with 5%
sheep blood by BD) or by Vitek. The results were inter-
preted in accordance with the 2009 CLSI (clinical labora-
tory standards institute) standards. When no inhibition
zone standards were available for an antimicrobial agent,
manufacturer information was used as reference. It should
be noted that CLSI and manufacturer breakpoints used to
define resistance for topically applied antibiotics are not
available and may differ considerably from systemic break-
points.24,25
Isolates were identified as methicillin-resistant Staphylo-
coccus aureus (MRSA) or methicillin-resistant Staphylococcus
pseudintermedius (MRSP 4) via positive growth on specialized
culture medium (Brilliance MRSA 2 Agar) and PBP2a
(penicillin binding protein 2A) expression.
Only samples where bacteria were identified to the spe-
cies level, or those with proven hemolysis were included
in the final antibiotic susceptibility results’ evaluation.
Antibiotics selected for susceptibility testing
The following antibiotics (or antibiotic classes) were
included in the analysis of antibiotic susceptibility, due to
their use in topical treatment protocols for septic keratitis
in veterinary ophthalmology: cephalosporin (depending on
the year of testing cefoperazone, cefalexin, cefoxitin, or
cefovecin was included), neomycin, gentamicin, tobramy-
cin, tetracycline, colistin (as substitute for polymyxin B),
enrofloxacin, norfloxacin, marbofloxacin (due to their par-
tial cross-resistance with ofloxacin, ciprofloxacin, and mox-
ifloxacin), fusidic acid, and bacitracin. Antibiotics for
which a variable effectivity against certain bacterial groups
has classically been observed were marked ‘*: variable sus-
ceptibility’ in the figures. Antibiotics against which, due to
pharmacological mechanisms, resistance occurs naturally
within certain bacterial groups were marked ‘#: intrinsic
resistance’ in the figures.
Statistics
Because this study is descriptive in nature, limited statis-
tical analyses were performed. Odds ratios (ORs) and
associated 95% confidence intervals (CIs) were estimated
© 2017 American College of Veterinary Ophthalmologists, Veterinary Ophthalmology, 1–10
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for all dog and cat breeds included in the study popula-
tion. The ORs thus represent the chance for a dog of a
specific breed to be presented with a septic corneal dis-
ease (as specified by the criteria in the Materials and
Methods section) in comparison with dogs of non-
brachycephalic breeds within the general hospital popu-
lation. Boxers, English Bulldogs, French Bulldogs, King
Charles Spaniels, Pekingeses, Boston Terriers, Continen-
tal Bulldogs, Shih Tzus, and Pugs were considered to
be brachycephalic dog breeds.26–28 Persian cats were
compared with non-Persian (mostly European short-
haired) cats, as the Persian cat was the only brachy-
cephalic cat breed analyzed.29 Additionally, for descrip-
tion of the breed-specific prevalences, binomial 95%
confidence intervals were estimated. Here, the estimated
breed-specific prevalences indicate the proportion of
affected individuals within the hospital population. The
statistics program R 3.1.2. was used for all statistical
calculations (R Core Team (2016). R: A language and
environment for statistical computing. R Foundation for
Statistical Computing, Vienna, Austria. URL https://
www.R-project.org/5 ).
RESULTS
Two hundred and fifty-five culture and antibiotic suscepti-
bility reports were reviewed. Ninety-six, 29, and 31 posi-
tive cultures were obtained from 89 canine, 28 feline, and
29 equine eyes, respectively. Repeated sampling of patients
(contralateral eye or ipsilateral eye but different septic ker-
atitis episode) accounted for the differences in number of
cultures and eyes. Negative cultures were obtained from
34% (50/146) canine, 52% (31/60) feline, and 37% (18/
49) equine samples.
Bacterial isolates
The isolates were not specified to exact bacterial species
in every case, resulting in a high number of isolates that
were specified up to genus level (e.g., Staphylococcus spp.)
or further specified only to a limited degree (e.g., hemoly-
tic Staphylococcus spp.).
In the staphylococci group, hemolytic Staphylococcus spp.
would likely be Staphylococcus (S.) aureus, S. pseudinter-
medius, or S. hemolyticus. According to recent systematic
research, S. intermedius is referred to as S. pseudinter-
medius.30,31 Consequently, all results mentioning S. inter-
medius were interpreted as S. pseudintermedius.
The most common bacterial isolates in canine patients
included Staphylococcus spp. (46 of 113 total isolates [40%]),
Streptococcus spp. (29/113 [25%]), Pseudomonas spp. (12/113
[10%]), Coliform spp. (9/113 [8%]), and Pasteurella spp. (8/
113 [7%]) (see Table 1). The most commonly isolated
Staphylococcus sp. was S. pseudintermedius (14/46 Staphylococ-
cus spp.). One of the S. pseudintermedius isolates was highly
suspicious to be classified as methicillin-resistant Staphylo-
coccus pseudintermedius (MRSP), and three isolates were
identified as MRSP. Beta-hemolytic streptococci repre-
sented 76% (22/29) of all Streptococcus isolates.
The most common bacterial infections in feline patients
included Staphylococcus spp. (21/32 [65%]), Streptococcus spp.
(4/32 [12%]) and Pasteurella spp. (2/32 [6%]), or aerobic
spore-forming bacteria (2/32 [6%]) (see Table 1). Two of
the feline Staphylococcus spp. isolates were suspicious for
methicillin resistance. One of the S. pseudintermedius iso-
lates was confirmed as MRSP.
No difference in prevalence of bacterial genera was
observed between brachycephalic breeds and mesocephalic
breeds in either dogs or cats (data not shown).
The most common bacterial isolates in equine patients
included Streptococcus spp. (16/35 [45%]), Staphylococcus spp.
(12/35 [34%]), and Pseudomonas spp. (2/35 [5%]) or Coli-
form bacteria (2/35 [5%]) (see Table 1). One of the
equine Staphylococcus isolates was suspicious for methi-
cillin resistance. One of the S. pseudintermedius isolates was
confirmed as MRSP.
Antibiotic susceptibility
There is a difference in the number of isolates and num-
ber of susceptibility test results because susceptibility test-
ing was not performed on each isolate. This typically
applied to the individual bacterial species identified in
mixed infections, where only the suspected pathogen(s)
were tested. (Figs 1–3).
Using systemic breakpoint data, resistance to enrofloxa-
cin/norfloxacin was observed in 48% (15/31) of all staphy-
lococci and 19% (4/21) of all streptococci isolated from
dogs, with an additional 9% (3/31) and 52% (11/21)
demonstrating intermediate susceptibility, respectively.
Resistance to gentamicin was observed in 23% (dogs 7/
31), 7% (cats 1/14), and 50% (horses 2/4) of all staphylo-
cocci and in 95% (dogs 20/21) to 100% (horses 9/9, cats
3/3) of all Streptococcus spp. No P. aeruginosa isolates from
dogs were found to be resistant to gentamicin. A similar
resistance profile was observed for neomycin: 23% (dogs
7/31), 14% (cats 2/14), and 50% (horses 2/4) of all
staphylococci, all streptococci and 16% (2/12) of P. aerug-
inosa isolates from dogs were neomycin resistant.
Resistance to tetracycline was observed in 48% (dogs
15/31), 14% (cats 2/14), and 75% (horses 3/4) of all Sta-
phylococcus spp.; and 68% (dogs 15/22) and 44% (horses 4/
9) of all Streptococcus spp.
Resistance to cephalosporins was observed in 16% (5/
31) of all Staphylococcus spp. from dogs (14% cats, 2/14;
75% horses, 3/4). All Streptococcus spp. were susceptible.
Canine P. aeruginosa isolates were cephalosporin resistant
in 67% (8/12) of cases. Resistance to fusidic acid was
observed in 17% (dogs 5/30), 7% (cats 1/12), and 50%
(horses 2/4) of all Staphylococcus spp.
Only four isolates (three canine beta-hemolytic strepto-
cocci and one equine S. pseudintermedius) were resistant to
all three agents in the triple-antibiotic combination of
© 2017 American College of Veterinary Ophthalmologists, Veterinary Ophthalmology, 1–10
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neomycin, polymyxin B (colistin tested), and bacitracin. In
several other cases, complete resistance could not be ruled
out because one of the three antibiotics had either not
been tested on the isolate (14 cases: six staphylococci,
seven streptococci, one P. aeruginosa.; bacitracin not
tested) or yielded an intermediate susceptibility result
(seven cases).
Breed predispositions
Various breeds were represented in the study, among
them eight brachycephalic dog breeds and one brachy-
cephalic cat breed. The ORs for the presence of septic
keratitis and binomial 95% confidence intervals in evalu-
ated dog and cat breeds are listed in Table 2. Pugs had a
particularly high chance to present with septic keratitis
(OR: 70.39, CI: 42.49–116.62) compared to nonbrachy-
cephalic breeds with a large representation in the general
hospital reference population (Labrador Retriever: OR:
0.44, CI: 0.06–3.25; Mixed Breed: OR: 1.06, CI: 0.41–
2.72). In a similar fashion, English Bulldogs, French Bull-
dogs, Pekingese, and Shih Tzus are at increased risk for
having septic keratitis. Boston Terriers also had an
increased OR for septic keratitis, although low case num-
bers resulted in a wide confidence interval. Persian cats
also demonstrate a higher chance to be presented with
septic keratitis (OR: 12.21, CI: 5.71–26.10) compared to
Domestic Shorthair cats (OR 0.52, CI: 0.24–1.10), which
is the most prevalent nonbrachycephalic breed in the ref-
erence population.
Six percent of all canine and 5% of all feline patients
presented at the veterinary teaching hospital of the Vetsu-
isse Faculty, University of Zurich, were brachycephalic
(OblonData Praxissoftware). In comparison, 59% (53/89)
of the dogs and 39% (11/28) of the cats included in the
current study were brachycephalic.
DISCUSSION
Staphylococci and streptococci accounted for more than
66% of bacterial isolates from dogs, cats, and horses with
septic keratitis in this study. Almost 50% of the staphylo-
cocci isolated from dogs were resistant to second-genera-
tion fluoroquinolones. Brachycephalic animals were at
particularly high risk of having septic keratitis.
Staphylococci and streptococci accounted for 66% of
the bacterial isolates in dogs and 80% of the isolates in
cats and horses The isolation rates of ocular surface bacte-
ria and the percentages of negative cultures vary across
studies. Our findings correspond with those from previous
studies.7,8,12,14–18,32–40 Some of the studies cited above-
Table 1. Bacterial isolates from canine, feline and equine eyes with septic keratitis6
Isolate genus Isolate species
Total
isolates—canine eyes
113 (100%)
Total
Isolates—feline eyes
32 (100%)
Total
isolates—equine eyes
35 (100%)
Staphylococcus 46 (40.7%) 21 (65.6%) 12 (34.28%)
S. pseudintermedius 11 3 1
MRSP 3 1 1
S. aureus 8 1 1
Hemolytic Staphylococcus spp. 9 9 1
Unspecified (Staphylococcus spp.) 15 7 8
Streptococcus 29 (25.66%) 4 (12.5%) 16 (45.71%)
Beta-hemolytic Streptococcus 22 3 6
S. canis 1 0 0
S. equi ssp. zooepidemicus 0 0 3
Unspecified (Streptococcus spp.) 6 1 7
Pseudomonas 12 (10.62%) 1 (3.1%) 2 (5.71%)
P. aeruginosa 12 0 2
Unspecified (Pseudomonas spp.) 0 1 0
Pasteurella 8 (7.08%) 2 (6.3%) 0
P. multocida 7 1 0
Unspecified (Pasteurella spp.) 1 1 0
Coliform + Escherichia 9 (7.96%) 1 (3.1%) 2 (5.71%)
Escherichia E. coli 4 1 1
Coliform 5 0 1
Coryneform/Corynebacteria 3 (2.65%) 0 1 (2.85%)
Aerobic spore-formers 6 (5.31%) 2 (6.3%) 1 (2.85%)
B. cereus 4 1 0
Unspecified 2 1 1
Gram-positive anaerobic rods 0 1 (3.1%) 0
Enterococci 0 0 1 (2.85%)
An overview of the bacterial isolates collected from clinical patients examined by the ophthalmology section at the Vetsuisse Faculty, University
of Zurich between January 2009 and December 2013.
© 2017 American College of Veterinary Ophthalmologists, Veterinary Ophthalmology, 1–10
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Figure 1.7 Antibiotic susceptibility of most
commonly isolated bacterial pathogens from dogs
with septic keratitis. (a) antibiotic susceptibility of
Staphylococcus spp. isolated from dogs. (b) antibiotic
susceptibility of Streptococcus spp. isolated from
dogs. (c) antibiotic susceptibility of Pseudomonas
aeruginosa isolated from dogs. Included were all
Staphylococcus spp. known to be pathogenic;
S. pseudintermedius, S. epidermidis, S. aureus,
methicillin-resistant Staphylococcus pseudintermedius,
and those with proven hemolysis (hemolytic
staphylococci). Specified Streptococcus isolates from
dogs were mostly beta-hemolytic Streptococcus spp.,
except one S. canis isolate. The total number of
isolates is listed on the left. Not all antibiotics
were tested on all isolates; therefore, the numbers
in the bars differ from the total number of
isolates. Antibiotics for which a variable effectivity
against certain bacterial groups has classically
been observed were marked ‘*: variable
susceptibility’ in the figures. Antibiotics against
which, due to pharmacological mechanisms,
resistance occurs naturally within certain bacterial
groups were marked ‘#: intrinsic resistance’ in the
figures. Agar disk diffusion tests were interpreted
in accordance with CLSI (clinical laboratory
standards institute) standards or manufacturer-
supplied breakpoints to define resistance as ‘S’:
sensitive; ‘I’: intermediate sensitivity or ‘R’:
resistant. Such breakpoints are based on
concentrations that may be reached in plasma,
and breakpoints for topically applied antibiotics
have not been established. This is important
because clinical susceptibility depends on the
corneal concentration and bioavailability of
topically applied antibiotics, which can lie orders
of magnitude above safely reachable plasma
concentrations.
© 2017 American College of Veterinary Ophthalmologists, Veterinary Ophthalmology, 1–10
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reported higher isolation rates for P. aeruginosa and lower
isolation rates for beta-hemolytic streptococci in dogs8,14
and higher isolation rates for P. aeruginosa in dogs 12 and
in horses15,16 in comparison with the current study. The
differences in bacterial isolation rates reported in compa-
rable studies12,32,33 might be related to smaller study sam-
ple sizes, geographical/climatic differences, and/or
differences in analytic and interpretational methods.
Almost 50% (15/31) of canine Staphylococcus isolates
were resistant to the second-generation fluoroquinolones
enrofloxacin and norfloxacin, which suggests an increase
compared to previous reports. In 2006, Tolar et al.8 found
100% of staphylococci and streptococci to be susceptible
to enrofloxacin. Various reports in human medicine20–23
clearly suggest increased fluoroquinolone resistance. How-
ever, results vary between studies and other groups report
stable sensitivity to fluoroquinolones over time.41–43 Bacte-
rial resistance against third- and fourth- generation fluoro-
quinolones is still relatively rare but was observed in this
study and can logically be expected to increase as has
occurred for the first- and second- generation fluoro-
quinolones.20,22,44
Gentamicin is typically used against gram-negative
pathogens, with special efficacy against P. aeruginosa,19,45
which is supported by the results of this study. The
reported susceptibility of gram-positive bacteria for gen-
tamicin is variable.7,8,15–17,19,45,46 Gentamicin resistance
was observed in 95–100% of tested Streptococcus isolates in
our study.
Cephalosporins have typically been effective against
Streptococcus and Staphylococcus spp.19,47 Whereas cephalos-
porin resistance was not observed in Streptococcus spp., we
did demonstrate cephalosporin resistance in 16% of the
tested Staphylococcus isolates from dogs, which could be
an indication of emerging cephalosporin resistance in Sta-
phylococcus spp.
The same concern applies to the traditionally
antistaphylococcal antibiotic fusidic acid,19 to which 17%
of all tested staphylococci in this study was resistant.
The intrinsic resistance of Staphylococcus and Streptococcus
spp. to polymyxin B and of Streptococcus spp. to neomycin
was confirmed with 100% of resistant isolates in this
study. Effectivity against Staphylococcus isolates was vari-
able for neomycin. Resistance to neomycin and polymyxin
B was observed in 16% of canine P. aeruginosa isolates.
These results support the reported variable neomycin
resistance in Staphylococcus spp. and Pseudomonas spp.
strains.7,8 Pseudomonas isolates are routinely susceptible
to polymyxin B, and acquired resistance reportedly is
rare.48
Figure 2. Antibiotic susceptibility of Staphylococcus spp. isolated from cats with septic keratitis. Fourteen pathogenic Staphylococcus isolates were
analyzed: three S. pseudintermedius, one S. aureus, one methicillin-resistant Staphylococcus aureus, and nine other hemolytic Staphylococcus spp. Only
three Streptococcus isolates were sufficiently specified to be included in the data analysis. Therefore, a graph was not assembled for these cases.
The total number of isolates is listed on the left. Not all antibiotics were tested on all isolates; therefore, the numbers in the bars differ from the
total number of isolates. Antibiotics for which a variable effectivity against certain bacterial groups has classically been observed were marked ‘*:
variable susceptibility’ in the figures. Antibiotics against which, due to pharmacological mechanisms, resistance occurs naturally within certain
bacterial groups were marked ‘#: intrinsic resistance’ in the figures. Agar disk diffusion tests were interpreted in accordance with CLSI (clinical
laboratory standards institute) standards or manufacturer-supplied breakpoints to define resistance as ‘S’: sensitive; ‘I’: intermediate sensitivity or
‘R’: resistant. Such breakpoints are based on concentrations that may be reached in plasma, and breakpoints for topically applied antibiotics have
not been established. This is important because clinical susceptibility depends on the corneal concentration and bioavailability of topically
applied antibiotics, which can lie orders of magnitude above safely reachable plasma concentrations.
© 2017 American College of Veterinary Ophthalmologists, Veterinary Ophthalmology, 1–10
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Bacitracin is effective against gram-positive bacteria but
ineffective against gram-negative organisms. P. aeruginosa
has intrinsic resistance against bacitracin.19 Interestingly,
very few of our 180 bacterial isolates were proven to be
resistant against the triple-antibiotic combination of neo-
mycin, polymyxin B (colistin), and bacitracin (gramicidin).
However, due to its toxic and anaphylactic potential,
which precludes its systemic use in veterinary medicine,
bacitracin was not included in the panel of tested antibi-
otics in 14 cases in this study. Most of the Staphylococcus
and Streptococcus spp., which were isolated in 13 of these 14
cases, may have been sensitive to bacitracin as bacitracin
resistance was rare among our gram-positive isolates.
In the present study, the odds ratios for the presence of
septic keratitis were significantly increased for brachy-
cephalic individuals, and especially for Pugs, compared to
the general mesocephalic canine hospital population. For
comparative and descriptive reasons, ORs were listed for
all dog breeds represented in the study population. How-
ever, some of the ORs listed were likely coincidental, espe-
cially for breeds with only one individual representing the
breed in the study population and low case numbers in the
Figure 3. Antibiotic susceptibility of most
commonly isolated bacterial pathogens from
horses with septic keratitis. (a) antibiotic
susceptibility of Staphylococcus spp. isolated from
horses. (b) antibiotic susceptibility of Streptococcus
spp. isolated from horses. The 4 equine
Staphylococcus isolates in (a) included one
S. pseudintermedius, one S. aureus, one methicillin-
resistant Staphylococcus pseudintermedius, and one
additional hemolytic Staphylococcus. The
Streptococcus isolates in (b) included six beta-
hemolytic Streptococcus spp. and three S. equi ssp.
zooepidemicus. The total number of isolates is
listed on the left. Not all antibiotics were tested
on all isolates; therefore, the numbers in the bars
differ from the total number of isolates.
Antibiotics for which a variable effectivity against
certain bacterial groups has classically been
observed were marked ‘*: variable susceptibility’
in the figures. Antibiotics against which, due to
pharmacological mechanisms, resistance occurs
naturally within certain bacterial groups were
marked ‘#: intrinsic resistance’ in the figures. Agar
disk diffusion tests were interpreted in accordance
with CLSI (clinical laboratory standards institute)
standards or manufacturer-supplied breakpoints to
define resistance as ‘S’: sensitive; ‘I’: intermediate
sensitivity or ‘R’: resistant. Such breakpoints are
based on concentrations that may be reached in
plasma, and breakpoints for topically applied
antibiotics have not been established. This is
important because clinical susceptibility depends
on the corneal concentration and bioavailability of
topically applied antibiotics, which can lie orders
of magnitude above safely reachable plasma
concentrations.
© 2017 American College of Veterinary Ophthalmologists, Veterinary Ophthalmology, 1–10
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reference population. In this study, the Toy Terrier breed,
with one individual representing the breed in the study
population and 13 dogs representing the breed in the refer-
ence population (OR: 132.97, CI: 16.94–1043.32), is an
example of a likely coincidentally increased OR with a
wide CI suggesting great statistical uncertainty. Packer
et al.49 reported that brachycephalism (20x), the presence
of nasal folds (5x), a 10% increase in relative eyelid aper-
ture width (3x), and exposed scleral tissue (3x) predispose
dogs to the development of corneal ulceration by the mul-
tiplication factors listed between parentheses. Thus, factors
contributing to a link between brachycephalism and septic
keratitis likely include the combination of relative exoph-
thalmos and macroblepharon that leads to lagophthalmos.
Limitations of this study include the following: CSLI or
manufacturer-supplied breakpoints used to define antibi-
otic resistance are based on concentrations that may be
reached in plasma, and breakpoints for topically applied
antibiotics have not been established. This is important
because clinical susceptibility depends on the corneal
concentration and bioavailability of topically applied
antibiotics, which can lie orders of magnitude above safely
reachable plasma concentrations.25 Therefore, bacterial
isolates that are determined to be ‘intermediately suscepti-
ble’ or ‘resistant’ based on agar disk diffusion susceptibility
testing with CLSI breakpoints can be clinically susceptible
to the antibiotic in question.
Various groups have presented minimal inhibitory con-
centrations (MICs) for combinations of bacterial isolates
and antibiotics.24,50,51 Kaye et al.24 have demonstrated an
association between the MICs for certain bacteria/antibi-
otic combinations and the clinical outcome for human
patients with septic keratitis. The availability and presen-
tation of minimal inhibitory concentrations (MICs) for the
isolate/drug combinations tested in this study would
therefore have been preferable. However, MIC values
were not available during the timeframe of the study as
the test results were reported by the diagnostic laboratory
as S (sensitive), I (intermediate), or R (resistant) without
actual inhibition zone measurements.
Table 2. Odds ratios for the presence of septic keratitis (see main text for further details)
Breed Cases
Reference
hospital
population
OR (confidence
interval)
Breed-specific prevalence
(Binomial 95%
(confidence interval)
Alaskan Malamute 1 150 11.52 (1.56–84.59) 0.6% (0.01–3.6%)
Appenzeller 2 553 6.25 (1.50–26.02) 0.36% (0.04–1.2%)
Australian Shepherd 1 412 4.19 (0.57–30.67) 0.24% (0.006–1%)
Beagle 1 740 2.33 (0.31–17.06) 0.13% (0.003–0.7%)
Bloodhound 1 52 33.24 (4.47–246.99) 1.8% (0.04–10%)
Boston Terrier 3 85 61.01 (18.43–201.92) 3.4% (0.7–9.6%)
Boxer 2 1650 2.09 (0.50–8.70) 0.12% (0.01–0.4%)
Berner Sennenhund 1 1815 0.95 (0.13–6.95) 0.05% (0.001–0.3%)
Cairn Terrier 2 469 7.37 (1.76–30.70) 0.42% (0.05–1.5%)
Cavalier King Charles Spaniel 1 187 9.24 (1.26–67.77) 0.5% (0.01–2.9%)
Chihuahua 4 1074 6.43 (2.28–18.11) 0.3% (0.1–0.9%)
Cocker Spaniel 3 1209 4.28 (1.31–13.94) 0.2% (0.05–0.7%)
Continental Bulldog 1 139 12.43 (1.69–91.33) 0.7% (0.01–3.9%)
English Bulldog 4 273 25.32 (8.95–71.64) 1.4% (0.3–3.6%)
Flat Coated Retriever 1 1133 1.52 (0.20–11.13) 0.08% (0.002–0.4%)
French Bulldog 6 607 17.08 (7.17–40.7) 0.9% (0.3–2.1%)
Kleinspitz 1 27 64.02 (8.47–483.83) 3.5% (0.09–18.3%)
Labrador Retriever 1 3878 0.44 (0.06–3.25) 0.02% (0.0006–0.1%)
Luzerner Laufhund 1 41 42.16 (5.64–314.81) 0.2% (0.06–12.5%)
Maltese 1 404 4.27 (0.58–31.28) 0.2% (0.006–1.3%)
Mixed Breed 5 8086 1.06 (0.41–2.72) 0.06% (0.02–0.1%)
Pekingese 5 393 21.99 (8.58–56.33) 1.2% (0.4–2.9%)
Poodle 2 448 7.71 (1.85–32.14) 0.4% (0.05–1.5%)
Pug 27 663 70.39 (42.49–116.62) 3.9% (2.5–5.6%)
Shih Tzu 5 275 31.42 (12.24–80.69) 1.7% (0.5–4.1%)
Toy Terrier 1 13 132.97 (16.94–1043.32) 7.1% (0.1–33.8%)
Weimaraner 1 116 14.90 (2.02–109.59) 0.8% (0.02–4.6%)
West Highland White Terrier 2 1221 2.83 (0.68–11.77) 0.1% (0.01–0.5%)
Yorkshire Terrier 3 1571 3.30 (1.01–10.73) 0.1% (0.03–0.5%)
Persian Cat 11 1916 12.21 (5.71–26.10) 0.5% (0.2–1%)
Domestic Shorthair 16 25934 0.52 (0.24–1.10) 0.06% (0.03–0.1%)
Siamese 1 862 1.51 (0.20–11.14) 0.1% (0.002–0.6%)
Odds ratios for and breed-specific prevalence of septic keratitis in clinical patients examined by the ophthalmology section at the Vetsuisse Fac-
ulty, University of Zurich between January 2009 and December 2013.
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Despite the fact that the agar disk diffusion susceptibil-
ity test is a scientifically proven process which yields accu-
rate results with well-trained laboratory personnel, a
certain interobserver test bias as a result of an inherent
variability and potential subjectivity of manual inhibition
zone measurement needs to be taken into account. An
automated readout process would have eliminated such
potential interobserver variability of measurements within
the study and would potentially have increased the compa-
rability to other literature sources. The high number of
isolates classified as intermediate in some bacterial species
for certain antibiotic combinations might thus be
explained.
Due to the referral nature of the University of Zurich’s
veterinary ophthalmology clinic, almost all of the patients
were premedicated in some way, which might contribute
to higher resistance rates and a higher number of negative
cultures than in the actual general patient population.
Finally, only isolates that were clearly labeled on species
level and with known pathogenicity and those with proven
hemolysis were included in the evaluation of the antibiotic
susceptibility test results. This resulted in a decreased
study sample size for this part of the study.
In summary, the elevated odds ratios for septic keratitis
in brachycephalic breeds and the bacterial isolates identi-
fied in this study are consistent with previous studies. The
observed pathogen resistance against antimicrobial agents
(e.g., second-generation fluoroquinolones, cephalosporins,
potentially fusidic acid) is concerning and might be
reduced by prudent and, where possible, targeted use of
antibiotics. The use of neomycin–polymyxin B-bacitracin/
gramicidin triple-antibiotic combinations might be a valid
alternative to the first-line use of fluoroquinolones or
aminoglycosides for the treatment of septic keratitis.
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